iBio, Inc. ( IBIO) - Key Metrics
IBIO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | ? | ? | ? | ? |
| 2026Q2 | ? | -$0.09 | -$0.05 | -$0.06 |
| 2026Q1 | $0 | -$0.11 | -$0.11 | -$0.11 |
| 2025Q4 | $0.01 | -$0.31 | -$0.28 | -$0.28 |
| 2025Q3 | ? | -$0.49 | -$0.31 | -$0.32 |
IBIO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | ? | ? |
| 2026Q2 | ? | -5.32 |
| 2026Q1 | ? | -1.92 |
| 2025Q4 | ? | -0.61 |
| 2025Q3 | ? | -2.04 |
IBIO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | -2.68% | ? |
| 2026Q2 | -3.01% | ? |
| 2026Q1 | -12.99% | ? |
| 2025Q4 | -36.83% | ? |
| 2025Q3 | -7.87% | ? |
IBIO
Price: $1.38
52 week price:
Earnings Per Share: -0.56 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.7 million
Market Capitalization: 26.5 million